280
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Risk Factors for Treatment Drop-Out: Implications for Adverse Outcomes When Treating Opioid Use Disorder

, , DHSc, LCSW-R, MA, CASAC, , PhD & , MD
Pages 292-301 | Received 03 Jul 2019, Accepted 31 Oct 2019, Published online: 24 Nov 2020
 

ABSTRACT

Pathways to resolve the opioid epidemic focus on enhancing addiction treatment. Dropout rates from outpatient buprenorphine-naloxone (BN) treatment remain as high as 35% to 59%, contributing to poor treatment outcomes. Treatment interventions targeting retention require identification of dropout risk factors. This study used the New York State Office of Alcohol and Substance Abuse Services database to analyze patient information from an ancillary withdrawal management program. Binary logistic regression identified dropout trends. Use of alprazolam or cocaine and age (< 26 years old) correlated with increased likelihood of treatment drop-out. In contrast, a history of domestic violence or intimate partner violence, alcohol use, or prior hospitalization for a psychiatric disorder (hospital stay < 30 days) were associated with an increased likelihood of retention. Potentially modifiable dropout risk factors exist in BN treatment. Recommendations for treatment programs using BN treatment are included.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 53.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 200.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.